Key facts
- This page summarizes Jeff Cunningham's Form 4 filing for HEALTHSTREAM INC (HSTM).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 25 Mar 2022, 16:56.
Jeff Cunningham - 23 Mar 2022 Form 4 Insider Report for HEALTHSTREAM INC (HSTM)
- Reporting relationship
- Chief Technology Officer
- Issuer ticker
- HSTM
- Reported as of
- 23 Mar 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 25 Mar 2022, 16:56:59 UTC
- Prior SEC filing
- 18 Mar 2022
- Next SEC filing
- 31 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jeff Cunningham
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jeff Cunningham filed Form 4 for HEALTHSTREAM INC (HSTM) on 25 Mar 2022.
Change
- Previous filing in this sequence was filed on 18 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HSTM
holding
Common Stock Holding
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 13,401
- Date
- 23 Mar 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HSTM
transaction
Derivative
Restricted Share Units
Award
- Transaction value
- $0
- Shares
- +12,303
- Change %
- Price
- $0.000000
- Shares after
- 12,303
- Date
- 23 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,303
- Exercise price
- $0.000000
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted share unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the unit.
Footnote F2
Vesting of these RSUs is contingent upon continued service at the time of vesting and the achievement of certain performance criteria. The performance criteria will be established on an annual basis by the Compensation Committee of the Board of Directors. Up to 15% vest on March 23, 2023 for the period January 1, 2022 through December 31, 2022; up to 20% vest on March 23, 2024 for the period January 1, 2023 through December 31, 2023; up to 20% vest on March 23, 2025 for the period January 1, 2024 through December 31, 2024; up to 20% vest on March 23, 2026 for the period January 1, 2025 through December 31, 2025; and up to 25% vest on March 23, 2027 for the period January 1, 2026 through December 31, 2026. Vesting will be determined based on actual performance. RSUs that do not vest during a performance period may become eligible for vesting during the next performance period.
Footnote F3
Not applicable.